Featured Open Lecture: July-August 2024
Gene therapy in lipid metabolism and CVD by Prof Sekar Kathiresan Sekar Kathiresan is the Chief Executive Officer and founder of Verve Therapeutics, US. Previously,…
Gene therapy in lipid metabolism and CVD by Prof Sekar Kathiresan Sekar Kathiresan is the Chief Executive Officer and founder of Verve Therapeutics, US. Previously,…
We would like to extend our gratitude to all members who participated in the voting process. The election has now concluded. The votes will now…
Governance: Last days to vote in the EAS Executive Committee Elections This is your final reminder to cast your vote in the EAS Executive Committee…
Log in to view the election update. With less than a week remaining, we are excited to share the current election statistics with you. These…
Governance: Don’t wait to cast your vote. This is your opportunity to step up and contribute to making EAS even better Don’t wait to cast…
Log in to view the election update. With less than two weeks remaining, we are excited to share the current election statistics with you. These…
Governance: Your vote is your voice! Participate in the EAS Executive Committee Elections Your vote is your voice! Let us hear it by participating in…
The second EAS-LatAm webinar is swiftly approaching! Be part of our efforts to improve cardiovascular health. Engage with specialists, acquire valuable insights, and delve into…
Congress: Thank you for joining us at the EAS Congress 2024. See you next year in Glasgow, May 4-7! We would like to extend our…
Voting We are pleased to announce that voting is open and will be held via a website-based ballot, June 01 – 30, 2024. We invite…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.